Eprozinol
Names
Preferred IUPAC name
3-[4-(2-Methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-1-ol
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.046.482
KEGG
UNII
  • InChI=1S/C22H30N2O2/c1-26-22(20-10-6-3-7-11-20)18-24-16-14-23(15-17-24)13-12-21(25)19-8-4-2-5-9-19/h2-11,21-22,25H,12-18H2,1H3 ☒N
    Key: QSRHLIUOSXVKTG-UHFFFAOYSA-N ☒N
  • COC(CN1CCN(CC1)CCC(C2=CC=CC=C2)O)C3=CC=CC=C3
Properties
C22H30N2O2
Molar mass 354.4858
Pharmacology
R03DX02 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

Eprozinol is a drug for obstructive airway disease.[1][2]

References

  1. ↑ Nicrosini, F.; Carpinella, G. (1978). "Eprozinol treatment of chronic bronchitis with dyspnea and cough". Broncho-pneumologie. 28 (4): 322–327. PMID 756799.
  2. ↑ Labrid, C.; Duchene-Marullaz, P.; Rispat, G. (1981). "Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig". Pharmacology. 23 (1): 48–55. doi:10.1159/000137526. PMID 7312935.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.